Lorenzo F. Fanchi

机构：The Netherlands Cancer Institute, Oncode Institute · ORCID：0000-0002-5763-6726

发表论文 34 篇 · 总被引 5870 次 · h-index 17

代表论文

• Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers (2020 · Nature Medicine · 被引 1432)
• Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (2018 · Nature Medicine · 被引 868)
• Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers (2018 · Nature Medicine · 被引 594)
• Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction (2020 · Cell · 被引 557)
• Tumor organoid–T-cell coculture systems (2019 · Nature Protocols · 被引 403)
• Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection (2020 · Nature Immunology · 被引 119)